Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Capital Expenditures (2024 - 2025)

Historic Capital Expenditures for Kestra Medical Technologies (KMTS) over the last 2 years, with Q4 2025 value amounting to $7.3 million.

  • Kestra Medical Technologies' Capital Expenditures rose 6336.86% to $7.3 million in Q4 2025 from the same period last year, while for Oct 2025 it was $26.9 million, marking a year-over-year change of. This contributed to the annual value of $22.9 million for FY2025, which is 8760.02% up from last year.
  • Latest data reveals that Kestra Medical Technologies reported Capital Expenditures of $7.3 million as of Q4 2025, which was up 6336.86% from $8.2 million recorded in Q3 2025.
  • Over the past 5 years, Kestra Medical Technologies' Capital Expenditures peaked at $8.2 million during Q3 2025, and registered a low of $4.1 million during Q1 2025.